sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in Life Science REIT plc
The Vanguard Group, Inc. has filed a Form 8.3, revealing a stake in Life Science REIT plc. The disclosure is in accordance with Rule 8.3 of the Takeover Code, as Vanguard holds a 1% interest in relevant securities. The specific securities are the 1p ordinary shares, amounting to 3,511,201 shares.
The filing indicates a recent sale of 2,982 shares at 0.43 GBP each. No new subscriptions or cash-settled derivatives were reported. Vanguard clarified that no indemnity or agreements related to these securities are in place.
Additionally, the company reported no arrangements concerning voting rights or future acquisitions. As of May 14, 2025, there were no supplemental forms attached to the disclosure, marking a straightforward declaration of interests by Vanguard.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.